502 related articles for article (PubMed ID: 27157227)
1. Nivolumab-Induced Sarcoid-Like Granulomatous Reaction in a Patient With Advanced Melanoma.
Danlos FX; Pagès C; Baroudjian B; Vercellino L; Battistella M; Mimoun M; Jebali M; Bagot M; Tazi A; Lebbé C
Chest; 2016 May; 149(5):e133-6. PubMed ID: 27157227
[TBL] [Abstract][Full Text] [Related]
2. Immune checkpoint blocker-related sarcoid-like granulomatous inflammation: a rare adverse event detected in lymph node aspiration cytology of patients treated for advanced malignant melanoma.
Rodriguez EF; Lipson E; Suresh K; Cappelli LC; Monaco SE; Maleki Z
Hum Pathol; 2019 Sep; 91():69-76. PubMed ID: 31279873
[TBL] [Abstract][Full Text] [Related]
3. Granulomatous/sarcoid-like lesions associated with checkpoint inhibitors: a marker of therapy response in a subset of melanoma patients.
Tetzlaff MT; Nelson KC; Diab A; Staerkel GA; Nagarajan P; Torres-Cabala CA; Chasen BA; Wargo JA; Prieto VG; Amaria RN; Curry JL
J Immunother Cancer; 2018 Feb; 6(1):14. PubMed ID: 29433571
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary sarcoid-like granulomatosis induced by nivolumab.
Montaudié H; Pradelli J; Passeron T; Lacour JP; Leroy S
Br J Dermatol; 2017 Apr; 176(4):1060-1063. PubMed ID: 27291635
[TBL] [Abstract][Full Text] [Related]
5. Mediastinal FDG-positive lymph nodes simulating melanoma progression: drug-induced sarcoidosis like/lymphadenopathy related to ipilimumab.
González-Cruz C; Bodet D; Muñoz-Couselo E; García-Patos V
BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33509865
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced sarcoidosis-like reaction in adjuvant immunotherapy: Increased rate and mimicker of metastasis.
Chorti E; Kanaki T; Zimmer L; Hadaschik E; Ugurel S; Gratsias E; Roesch A; Bonella F; Wessendorf TE; Wälscher J; Theegarten D; Schadendorf D; Livingstone E
Eur J Cancer; 2020 May; 131():18-26. PubMed ID: 32248071
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy-Induced Sarcoid-Like Reaction: A Shrewd Imitator.
Yasin H; Yadala V; Khan NAJ; Graffeo V; Denning K; Lebowicz Y
J Investig Med High Impact Case Rep; 2021; 9():23247096211009400. PubMed ID: 33847154
[TBL] [Abstract][Full Text] [Related]
8. Granulomatous Tumoral Melanosis Associated With Pembrolizumab Therapy: A Mimicker of Disease Progression in Metastatic Melanoma.
Woodbeck R; Metelitsa AI; Naert KA
Am J Dermatopathol; 2018 Jul; 40(7):523-526. PubMed ID: 29924748
[TBL] [Abstract][Full Text] [Related]
9. Sarcoidosis-like syndrome and lymphadenopathy due to checkpoint inhibitors.
Firwana B; Ravilla R; Raval M; Hutchins L; Mahmoud F
J Oncol Pharm Pract; 2017 Dec; 23(8):620-624. PubMed ID: 27590328
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of Nivolumab in Patients With BRAF V600 Mutant and BRAF Wild-Type Advanced Melanoma: A Pooled Analysis of 4 Clinical Trials.
Larkin J; Lao CD; Urba WJ; McDermott DF; Horak C; Jiang J; Wolchok JD
JAMA Oncol; 2015 Jul; 1(4):433-40. PubMed ID: 26181250
[TBL] [Abstract][Full Text] [Related]
11. Sarcoid-like reaction and vitiligo occurring after nivolumab therapy in a patient with metastatic melanoma.
Fukuchi K; Hikawa M; Sano Y; Kasuya A; Aoshima M; Tatsuno K; Nakamura Y; Kosugi I; Tokura Y
J Dermatol; 2019 Oct; 46(10):e359-e360. PubMed ID: 30985014
[No Abstract] [Full Text] [Related]
12. Sarcoid-like reaction in sentinel lymph node draining conjunctival melanoma.
Rubinstein TJ; Plesec TP; Singh AD
Ophthalmic Plast Reconstr Surg; 2015; 31(1):e1-3. PubMed ID: 24833441
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy-induced sarcoidosis in patients with melanoma treated with PD-1 checkpoint inhibitors: Case series and immunophenotypic analysis.
Lomax AJ; McGuire HM; McNeil C; Choi CJ; Hersey P; Karikios D; Shannon K; van Hal S; Carr U; Crotty A; Gupta SK; Hollingsworth J; Kim H; Fazekas de St Groth B; McGill N
Int J Rheum Dis; 2017 Sep; 20(9):1277-1285. PubMed ID: 28480561
[TBL] [Abstract][Full Text] [Related]
14. Uveitis induced by programmed cell death protein 1 inhibitor therapy with nivolumab in metastatic melanoma patient.
Kanno H; Ishida K; Yamada W; Nishida T; Takahashi N; Mochizuki K; Mizuno Y; Matsuyama K; Takahashi T; Seishima M
J Infect Chemother; 2017 Nov; 23(11):774-777. PubMed ID: 28527652
[TBL] [Abstract][Full Text] [Related]
15. [Sarcoid-like granulomatosis in cancer patients treated with immune checkpoints inhibitors].
Faviez G; Bousquet E; Rabeau A; Rouquette I; Collot S; Goumarre C; Meyer N; Prevot G; Mazieres J
Rev Mal Respir; 2018 Nov; 35(9):963-967. PubMed ID: 30220489
[TBL] [Abstract][Full Text] [Related]
16. Interferon-induced cutaneous sarcoidosis in melanoma.
Suárez-García C; Pérez-Gil A; Pereira-Gallardo S; Codes-Villena M; García-Escudero A; Miguel Camacho F
Melanoma Res; 2009 Dec; 19(6):391-4. PubMed ID: 19770687
[TBL] [Abstract][Full Text] [Related]
17. Subacute CNS Demyelination after Treatment with Nivolumab for Melanoma.
Maurice C; Schneider R; Kiehl TR; Bavi P; Roehrl MH; Mason WP; Hogg D
Cancer Immunol Res; 2015 Dec; 3(12):1299-302. PubMed ID: 26419960
[TBL] [Abstract][Full Text] [Related]
18. Sarcoid-like granulomatous disease following etanercept treatment for RA.
Kudrin A; Chilvers ER; Ginawi A; Hazleman BL; Griffiths MH; Thiru S; Ostor AJ
J Rheumatol; 2007 Mar; 34(3):648-9. PubMed ID: 17343313
[No Abstract] [Full Text] [Related]
19. Sarcoid-like reactions in patients receiving modern melanoma treatment.
Dimitriou F; Frauchiger AL; Urosevic-Maiwald M; Naegeli MC; Goldinger SM; Barysch M; Franzen D; Kamarachev J; Braun R; Dummer R; Mangana J
Melanoma Res; 2018 Jun; 28(3):230-236. PubMed ID: 29485531
[TBL] [Abstract][Full Text] [Related]
20. Thoracic and cutaneous sarcoid-like reaction associated with anti-PD-1 therapy: longitudinal monitoring of PD-1 and PD-L1 expression after stopping treatment.
Paolini L; Poli C; Blanchard S; Urban T; Croué A; Rousselet MC; Le Roux S; Labarrière N; Jeannin P; Hureaux J
J Immunother Cancer; 2018 Jun; 6(1):52. PubMed ID: 29898781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
